Scott Holbrook
Chief Commercial and Manufacturing Officer at Ratio Therapeutics
Johnson City, Tennessee, United States
Find your path to Scott
18 people in our graph share verified history with Scott — schools, employers, funds. One of them is your warm intro.
Jameson HartmanunlockedScott: together at University of Utah (2025–2026)
×9Scott: together at University of Utah
Scott: together at Regis College
Scott: together at Cardiovascular Associates of America
Chief Commercial and Manufacturing Officer at Ratio Therapeutics
Intro paths
→
In turn, Scott can intro founders to Ratio Therapeutics's investors below.
Ratio Therapeutics's investors · 1
Co-founders at Ratio Therapeutics
JB
John BabichDirector, President & Chief Scientific Officer
JH
Jack HoppinChairman & Chief Executive Officer
Experience
- Ratio TherapeuticsAdvisorcurrent2026 — present
- Ratio TherapeuticsChief Commercial and Manufacturing Officer2025 — 2026Boston, MA
- NusanoChairman of the Boardcurrent2024 — present
- Pharmalogic Holdings Corp.Advisorcurrent2016 — presentBoca Raton Florida
- Cardiovascular Associates of AmericaBoard Advisorcurrent2021 — present
- University of UtahAdjunct Assistant Professor, Department of Radiologycurrent2021 — presentSalt Lake City, Utah
- Invivo Molecular Imaging and Precision Nuclear LLC.Co-Foundercurrent2010 — presentGray, TN
Skills & more
Good Manufacturing Practice (GMP)Drug DevelopmentCommercializationBusiness DevelopmentClinical PracticesCompany founderQuality and regulatoryExecutive ManagementPrivate EquityTargeted radiotherapyArtificial Intelligence (AI)
From Scott's professional profile.
Frequently asked questions
- Who is Scott Holbrook?
- Chief Commercial and Manufacturing Officer at Ratio Therapeutics
- Where does Scott Holbrook work?
- Scott Holbrook is Chief Commercial and Manufacturing Officer at Ratio Therapeutics.
- Where did Scott Holbrook go to school?
- Scott Holbrook studied at Regis College (Master of Science - MS, Molecular Imaging and Therapy); Wheeling Jesuit (Bachelor of Science - BS, Clinical Nuclear Medicine).
